Copyright © 2006 Bay Area Reporter, a division of Benro Enterprises, Inc. AIDS activists upset by dropped wasting drugby Heather Cassellh.cassell@ebar.com AIDS activists are mobilizing after Watson Pharmaceuticals last month dropped a common off-label drug used to assist patients with combating wasting and picked up a generic brand of an approved AIDS-related wasting medication that …
Surviving HIV Resistance in the new era of HAART Date: 04/25/2007 Time: 12-2 p.m. Place: Doubletree Hotel Address: 700 King St. City: Wilmington State: Delaware Zip: 19801 Contact Person: Lori Campbell Organization/Company: AIDS Delaware Contact Email: campbell@aidsdelaware.org Contact Phone: 302-652-6776 Contact Fax: Event Description: A lecture for patients and clinicians. Topics include how to avoid …
Compounded medications have greatly improved the quality of the lives of many people living with HIV. Several of these medications (hormone therapies, wasting therapies, quality of life therapies) are not cover by most insurance or ADAP/Medicare/Medicaid formularies, so patients rely on access through compounding pharmacies. Now, access to these medications is facing a huge threat. …
STOP CONGRESS FROM DENYING US COMPOUNDED MEDICINES Read More »
FOR MORE INFORMATION ABOUT THIS GO TO https://watsonboycott.blogspot.com/ April 4, 2007 Allen Chao, PhD Chairman and CEO Watson Pharmaceuticals Corporate Headquarters311 Bonnie CircleCorona, California 92880 Dear Dr Chao : I am writing to ask you to reverse your decision of stopping the manufacture of nandrolone decanoate. I am a national treatment advocate and person living …
WATSON PHARMACEUTICALS ABANDONS AIDS WASTING DRUG Read More »
Title: Latest Update on HIV Research Seminar date : April 19, Thursday Time: 6:00 pm til 8:30 pm Free dinner and door prizes Speakers: Shannon Schrader MD Nelson Vergel (powerusa.org) LOCATION:United Way of the Texas Gulf Coast50 Waugh DriveHouston, Texas 77007 For more information email : nelsonvergel@yahoo.com
From a meeting held by the Forum of Collaborative HIV Research. The list of participants is at the end of the letter. I certainly hope that the FDA encourages industry to implement these recommendations. Great ideas have died due to lack of action. March 11, 2007 The Forum for Collaborative HIV Research, an independent public/private …
Please read the article written by Enid Vazquez in the latest Positively Aware, one of the main free HIV magazines distributed around the U.S. My comments are in the last part in the section called “Don’t do as I did” I want to make sure that people who are applying for TMC 125 expanded access …
The number of salvage patients may be calculated with some current data and assumptions:450,000 under treatment in the US Assume: aconservative high estimate of 60 % of patients treated have undetectable viral load (under 50 copies per ml)(from 96 week studies of different drugs) so, 40 % have over 50 copies per ml out of …
How many people are in dire need for new HIV meds in the US in 2007 Read More »
Dear Nelson and Friends, I read with interest the attached excellent review of treatment strategies for PRN Notebook by Dr’s Charles Farthing and Athe Tsibris. I believe and feel strongly that two incorrect conclusions might be drawn from the studies presented in article that could adversely effect treatment strategy in individual patients. 1. Firstly, the …
Comments from Dr Paul Bellman about HIV rescue therapy Read More »
Now, patients with HIV multidrug resistance can start three active drugs in three different expanded access programs! This is the first time this has been possible in the 25 years of the AIDS epidemic. The closest thing to this wonderful time was the 1996-1998 period. This information was provided by Merck (Feb 20, 2007): Co-Administration …
The second wave of HAART: Combining MK 518 plus TMC 125 or Maraviroc Read More »
Prior to joining Merck’s phase III, my CD4 cells wereon their way down ….from 540 three years ago to 300, then to 200’s and finally to 180 in April 2006.My viral load set point was around 15,000-30,000 for years until April 2006 (VL then = 69,000). I have extensive PI , non nuke and nuke …
My experience with MK 518 and Prezista..and thoughts about TNX 355 Read More »
First watch this cool video that explains how Maraviroc workshttps://www.maraviroceap.com/interested_healthcare_professional/ccr5_tropism_video.aspx Overview and Registration for the Maraviroc EAP——————————————————————————– Overview of the Maraviroc EAPWelcome to the Maraviroc EAP Website. Maraviroc is an investigational drug being developed for use in combination with other antiretroviral medications for the treatment of human immunodeficiency virus, type-1 (HIV-1) infected treatment-experienced patients. Maraviroc …
Maraviroc, a new entry inhibitor, available via expanded access Read More »
